NCT02814058 - Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg Formulation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 5, 2017

Primary Completion Date

February 22, 2018

Study Completion Date

February 22, 2018

Conditions

Healthy

Interventions

DRUG

zolpidem hemitartarate 1.75 mg - Sequency 1

zolpidem hemitartarate 1.75 mg in fasting (period 1) and zolpidem hemitartarate 1.75 mg postprandial (period 2)

DRUG

zolpidem hemitartarate 1.75 mg - Sequency 2

zolpidem hemitartarate 1.75 mg postprandial (period 1) and zolpidem hemitartarate 1.75 mg in fasting (period 2)

Trial Locations (1)

UNIFAG - Unidade Integrada de Farmacologia e Gastroenterologia, Bragança Paulista